Treatment

James H. Beaty, Charles A. Rockwood, James R. Kasser. Pathologic Fractures Associated with Tumours and Unique Conditions of Musculoskeletal System. Ed: James H. Beaty. Rockwood and Wilkins’ Fractures in Children, 6th edition. Pp 120-190. Lippincott Williams & Wilkins Publishers 2011.

Goldblatt J, Sacks S, Beington P. Orthopaedic aspects of Gaucher disease. Clin Orthop. 1978;(137):208-214.

Campanacci M., Capanna R., Picci P. Unicameral and aneurysmal bone cysts. Clin Orthop 1986;204:25-36.

Oppenheim WL, Galleno H. Operative treatment versus steroid injection in the management of unicameral bone cysts. J Pediatr Orthop 1984;4(1):1-7.

Marcove RC, Sheth DS, Brien EW. The treatment of aneurysmal bone cysts. Clin Orthop 1995;(311):157-163.

Ehara S, Kattapuram SV, Egglin TK. Ewing‘s sarcoma: Radiographic pattern of healing and bony complications in patients with long-term survival. Cancer. 1991;68(7): 1531–1535.

Pochanugool L, Subhadharaphandou T, Dhanachai M. Prognostic factors among 130 patients with osteosarcoma. Clin Orthop. 1997;345:206–214.

Gafni RI, McCarthy EF, Hatcher T,Meyers JL, Inoue N, Reddy C, Weise M, Barnes KM, Abad V, Baron J. Recovery from osteoporosis through skeletal growth: early bonemass acquisition has little effect on adult bone density. FASEB J. 2002;16:736–738.

Patel DR. Stress fractures: diagnosis and management in the primary care setting. Pediatr Clin North Am. 2010;57:819–827.

Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr. 2010;135:115–117.

Caulton JM, WardKA, Alsop CW, Dunn G, Adams JE, Mughal MZ. A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy. Arch Dis Child. 2004; 89:131–135.

Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom. 2008;11:22–28.

Akcay T, Turan S, Guran T, Bereket A. Alendronate treatment in children with osteogenesis imperfecta. Indian Pediatr. 2008 Feb;45(2):105-9

DiMeglio LA, PeacockM. Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta. J Bone Miner Res. 2006;21:132–140.

Brumsen C, Hamdy NA, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore). 1997;76:266–283.

Streeten EA, McBride D, Puffenberger E, Hoffman ME, Pollin TI, Donnelly P, Sack P, Morton H. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates. Bone. 2008;43:584–590

Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. 2002;141:644–651.

El-Husseini AA, El-Agroudy AE, El-Sayed MF, SobhMA, Ghoneim MA. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents. Pediatr Transplant. 2004;8:357–361.

Ward L, TriccoAC, Phuong P,Cranney A, Barrowman N, Gaboury I, Rauch F, Tugwell P, Moher D. Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev: CD005324.

Bachrach LK,Ward LM. Clinical review1: bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab. 2009;94:400–409.

Gandrud LM, Cheung JC, Daniels MW, Bachrach LK. Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. J Pediatr Endocrinol Metab. 2003;16:887–892.

Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab. 2010;95:1555–1565.

Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr. 2008;153:719–720.

Ghoneima AA, Allam ES, Zunt SL, Windsor LJ. Bisphosphonates treatment and orthodontic considerations. Orthod Craniofac Res. 2010;13:1–10.

Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med. 2007;356:1075–1076.

Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999; 60:68–73.

Levy S, Fayez I, Taguchi N, Han JY, Aiello J,Matsui D,Moretti M, KorenG, Ito S. Pregnancy outcome following in utero exposure to bisphosphonates. Bone. 2009;44:428–430.

Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res. 2008;23:1698–1707.

Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003;349:457–463.

Alharbi M, Pinto G, Finidori G, Souberbielle JC, Guillou F, Gaubicher S, Le Merrer M, Polak M. Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution. Horm Res. 2009;71:38–44.

Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res. 2004;19:1779–1786.

Sellmeyer DE. Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA. 2010;304:1480–1484.

Bianchi ML, Baim S, Bishop NJ, Gordon CM, Hans DB, Langman CB, Leonard MB, Kalkwarf HJ. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol. 2010; 25:37–47.

AlMuderis M, Azzopardi T, Cundy P. Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am. 2007;89:1511–1516.

James H. Beaty, Charles A. Rockwood, James R. Kasser. Pathologic Fractures Associated with Tumours and Unique Conditions of Musculoskeletal System. Ed: James H. Beaty. Rockwood and Wilkins’ Fractures in Children, 6th edition. Pp 120-190. Lippincott Williams & Wilkins Publishers 2011.

Amstrong DG, Nemfield JT, Gillespie R. Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management.Clin Orthop Relat Res. 1981;Sep;(159):111-22